2Yones SS,Palmer RA,Garibaldinos TT,et al.Randomized double-blind trial of the treatment of chronic plaque psoriasis:efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy[J].Arch Dermatol,2006,142(7):836-842.
4Gordon KB,Papp KA,Hamilton TK,et al.Efalizumab for patients with moderate to severe plaque psoriasis:a randomized controlled trial[J].JAMA,2003,290(23):3073-3080.
5Collins P,Wainwright NJ,Amorim I,et al.8-MOP PUVA for psoriasis:a comparison of a minimal phototoxic dose-based regimen with a skin-type approach[J].Br J Dermatol,1996,135(2):248-254.
6Stern RS,Armstrong RB,Anderson TF,et al.Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis:a randomized study[J].J Am Acad Dermatol,1986,15(3):546-552.
4Ellis CN, Krueger GG.Alefacept Clinical Study Group. Treatment of chronic plaque psoriasis by selective targeting of memory effector T Iymphocytes[J]. N Engl J Med,2001,345 (25) : 1853.
5Lehmann B, Knuschke P, Meurer M. Effect of UVB radiation emitted from the narrowband TL-01 lamp (311nm) on the calcitriol synthesis in organotypic cultures of keratinocytes [J]. ExpyDermatol, 2005, 14(2): 153.
6Weischer M, Blum A, Eberhard F, et al. No evidence for increased skin cancer risk in psoriasis patients treated with broad- band or narrowband UVB phototherapy: a fast retrospective study [J]. Aeta Derm Venereol, 2004, 84(5): 370.
7Grundmann-Kollmann M,Ludwig R, Zollner TM, et al. Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis [J]. J Am Acad Dermatol, 2004, 50 (5): 734.
